Regulus Therapeutics (RGLS) Short Interest Ratio & Short Volume → Move Your Money Before May 1 (From Stansberry Research) (Ad) Free RGLS Stock Alerts $2.42 +0.15 (+6.61%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Regulus Therapeutics Short Interest DataCurrent Short Volume6,270,000 sharesPrevious Short Volume5,420,000 sharesChange Vs. Previous Month+15.68%Dollar Volume Sold Short$17.43 millionShort Interest Ratio / Days to Cover2.1Last Record DateApril 15, 2024Outstanding Shares65,460,000 sharesFloat Size57,420,000 sharesShort Percent of Float10.92%Today's Trading Volume204,765 sharesAverage Trading Volume2,395,709 sharesToday's Volume Vs. Average9% Short Selling Regulus Therapeutics ? Sign up to receive the latest short interest report for Regulus Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRGLS Short Interest Over TimeRGLS Days to Cover Over TimeRGLS Percentage of Float Shorted Over Time Ad Weiss RatingsProtect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. Regulus Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20246,270,000 shares $17.43 million +15.7%10.9%2.1 $2.78 3/31/20245,420,000 shares $15.61 million +5.7%9.4%1.8 $2.88 3/15/20245,130,000 shares $10.82 million +9,244.3%13.0%1.8 $2.11 2/29/202454,900 shares $80,703.00 -43.4%0.3%1.4 $1.47 2/15/202497,000 shares $143,560.00 -16.6%0.6%2.6 $1.48 1/31/2024116,300 shares $147,701.00 -7.3%0.7%4.4 $1.27 Get the Latest News and Ratings for RGLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Regulus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024125,500 shares $163,150.00 -9.3%0.7%5.1 $1.30 12/31/2023138,400 shares $177,152.00 -6.6%0.8%6.9 $1.28 12/15/2023148,100 shares $202,897.00 -0.1%0.9%7.6 $1.37 11/30/2023148,200 shares $194,142.00 -18.3%0.9%4.4 $1.31 11/15/2023181,300 shares $252,007.00 -5.2%1.0%4.9 $1.39 10/31/2023191,200 shares $231,352.00 -0.7%1.1%5.4 $1.21 10/15/2023192,600 shares $242,676.00 -1.0%1.2%5.5 $1.26 9/30/2023194,500 shares $266,465.00 -0.2%1.2%5.6 $1.37 9/15/2023194,800 shares $331,160.00 +4.2%1.2%5.6 $1.70 8/31/2023187,000 shares $291,720.00 -10.2%1.1%5.7 $1.56 8/15/2023208,300 shares $281,205.00 -3.7%1.3%9.6 $1.35 7/31/2023216,300 shares $302,820.00 -3.9%1.3%7.8 $1.40 7/15/2023225,000 shares $328,500.00 -2.5%1.4%7.7 $1.46 6/30/2023230,700 shares $339,129.00 +6.5%1.4%4.1 $1.47 6/15/2023216,700 shares $312,048.00 +3.0%1.3%3.4 $1.44 5/31/2023210,300 shares $273,390.00 -17.1%1.3%3.1 $1.30 5/15/2023253,700 shares $393,235.00 +26.0%1.6%3.8 $1.55 4/30/2023201,300 shares $268,735.50 +18.1%1.4%3.4 $1.34 4/15/2023170,500 shares $202,895.00 -13.9%1.2%2.6 $1.19 3/31/2023198,000 shares $167,805.00 +11.1%1.3%4.8 $0.85 3/15/2023178,200 shares $215,622.00 -3.7%1.2%4 $1.21 2/28/2023185,100 shares $248,034.00 -1.9%1.3%4.1 $1.34 2/15/2023188,600 shares $262,154.00 -6.8%1.3%4.2 $1.39 1/31/2023202,400 shares $291,456.00 -3.2%1.4%4.3 $1.44 1/15/2023209,000 shares $311,410.00 +0.8%1.4%4.7 $1.49 12/30/2022207,400 shares $284,138.00 -10.8%1.4%4.7 $1.37 12/15/2022232,600 shares $327,966.00 -16.2%1.6%5.4 $1.41 11/30/2022277,500 shares $474,525.00 -2.6%1.9%0.3 $1.71 11/15/2022284,900 shares $490,028.00 +5.1%2.0%0.3 $1.72 10/31/2022271,100 shares $420,205.00 -1.7%N/A0.3 $1.55 10/15/2022275,900 shares $449,717.00 -7.4%N/A0.3 $1.63 9/30/2022297,900 shares $506,430.00 -49.9%N/A0.3 $1.70 9/15/2022594,600 shares $1.24 million +98.7%N/A0.7 $2.09 8/31/2022299,300 shares $425,006.00 -15.2%N/A0.4 $1.42Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.4 simple steps to protect your privacy and money before it’s too late. RGLS Short Interest - Frequently Asked Questions What is Regulus Therapeutics' current short interest? Short interest is the volume of Regulus Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 6,270,000 shares of RGLS short. 10.92% of Regulus Therapeutics' shares are currently sold short. Learn More on Regulus Therapeutics' current short interest. What is a good short interest ratio for Regulus Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGLS shares currently have a short interest ratio of 2.0. Learn More on Regulus Therapeutics's short interest ratio. What is a good short interest percentage for Regulus Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.92% of Regulus Therapeutics' floating shares are currently sold short. Is Regulus Therapeutics' short interest increasing or decreasing? Regulus Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 6,270,000 shares, an increase of 15.7% from the previous total of 5,420,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Regulus Therapeutics' float size? Regulus Therapeutics currently has issued a total of 65,460,000 shares. Some of Regulus Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Regulus Therapeutics currently has a public float of 57,420,000 shares. How does Regulus Therapeutics' short interest compare to its competitors? 10.92% of Regulus Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Regulus Therapeutics: Emergent BioSolutions Inc. (11.76%), Alimera Sciences, Inc. (0.21%), Rigel Pharmaceuticals, Inc. (2.95%), Merrimack Pharmaceuticals, Inc. (5.62%), Verastem, Inc. (3.94%), Bolt Biotherapeutics, Inc. (8.63%), Vanda Pharmaceuticals Inc. (3.80%), XOMA Co. (2.42%), Lexicon Pharmaceuticals, Inc. (8.17%), CervoMed Inc. (0.71%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Regulus Therapeutics stock? Short selling RGLS is an investing strategy that aims to generate trading profit from Regulus Therapeutics as its price is falling. RGLS shares are trading up $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Regulus Therapeutics? A short squeeze for Regulus Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RGLS, which in turn drives the price of the stock up even further. How often is Regulus Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGLS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Emergent BioSolutions Short Interest Alimera Sciences Short Interest Rigel Pharmaceuticals Short Interest Merrimack Pharmaceuticals Short Interest Verastem Short Interest Bolt Biotherapeutics Short Interest Vanda Pharmaceuticals Short Interest XOMA Short Interest Lexicon Pharmaceuticals Short Interest CervoMed Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RGLS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm Press